Generation of functional hepatocytes by forward programming with nuclear receptors

Author:

Tomaz Rute A12ORCID,Zacharis Ekaterini D12,Bachinger Fabian12,Wurmser Annabelle12,Yamamoto Daniel12,Petrus-Reurer Sandra2,Morell Carola M12,Dziedzicka Dominika12,Wesley Brandon T1,Geti Imbisaat12,Segeritz Charis-Patricia12,de Brito Miguel C12,Chhatriwala Mariya2,Ortmann Daniel12,Saeb-Parsy Kourosh2,Vallier Ludovic123ORCID

Affiliation:

1. Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge

2. Department of Surgery, University of Cambridge and NIHR Cambridge Biomedical Research Centre

3. Wellcome Sanger Institute, Wellcome Genome Campus

Abstract

Production of large quantities of hepatocytes remains a major challenge for a number of clinical applications in the biomedical field. Directed differentiation of human pluripotent stem cells (hPSCs) into hepatocyte-like cells (HLCs) provides an advantageous solution and a number of protocols have been developed for this purpose. However, these methods usually follow different steps of liver development in vitro, which is time consuming and requires complex culture conditions. In addition, HLCs lack the full repertoire of functionalities characterising primary hepatocytes. Here, we explore the interest of forward programming to generate hepatocytes from hPSCs and to bypass these limitations. This approach relies on the overexpression of three hepatocyte nuclear factors (HNF1A, HNF6, and FOXA3) in combination with different nuclear receptors expressed in the adult liver using the OPTi-OX platform. Forward programming allows for the rapid production of hepatocytes (FoP-Heps) with functional characteristics using a simplified process. We also uncovered that the overexpression of nuclear receptors such as RORc can enhance specific functionalities of FoP-Heps thereby validating its role in lipid/glucose metabolism. Together, our results show that forward programming could offer a versatile alternative to direct differentiation for generating hepatocytes in vitro.

Funder

European Research Council

UK Regenerative Medicine Platform

Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge

Gates Cambridge Trust

Chan Zuckerberg Initiative

bit.bio

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3